Search Results - technology+classifications+%3e+vaccines

21 Results
Sort By:

Skin‑targeted dual mRNA vaccine platform delivers long‑lasting protection against cutaneous leishmaniasis

A dual mRNA-LNP vaccine encoding Leishmania PEPCK and IL-12 to promote durable dermal-resident memory T cell responses.

Published: 10/21/2026

Fast, On-Demand Manufacturing of Room Temperature-Stable RNA

A method enabling facile synthesis and purification of RNA in a stable format that does not require cold chain distribution.

Published: 10/21/2026

Rapid Synthesis of Amidine-Incorporated Degradable Lipids for Non-Liver mRNA delivery

One-pot combinatorial chemistry for fast and facile synthesis of amidine-incorporated degradable cationic lipids for lipid nanoparticle formulation and non-liver nucleic acid delivery.

Published: 10/21/2026

Small Molecules That Expose HIV Env Sites To Trigger Targeted Immune Killing

This technology uses small molecules to bind HIV Env on infected cells, expose hidden sites, and trigger ADCC, enabling the immune system to kill cells that current therapies cannot reach. By improving antibody recognition and reducing infectious virus production, it provides a complementary approach that directly targets infected cells rather than only preventing new infections.

Published: 10/21/2026

Peptides For Solid Cancer Tumor Immunotherapy Treatment

Short, multivalent peptide antagonists to block macrophage immune-receptor SIRPα, promoting cancer cell phagocytosis.

Published: 10/21/2026

Methods and Sequences for mRNA and Other HIV Vaccine Development

Unique sequences eliciting broadly neutralizing antibodies (bNAbs) against human immunodeficiency virus (HIV) that could be used to develop effective mRNA-based and other types of HIV vaccine.

Published: 10/21/2026

Targeted Organ or Multiple Organ Delivery of mRNA with Ionizable Amphiphilic Janus Dendrimers

A library of easily synthesized ionizable amphiphilic Janus dendrimer (IAJD) compounds that deliver mRNA either to targeted organs or multiple organs, depending on the IAJD design.

Published: 10/21/2026

Universal cancer vaccine targeting tumor vasculature

A DNA vaccine targeting tumor endothelial marker 1 (TEM1) that allows to prevent and delay tumor progression without adverse effect on physiologic angiogenesis

Published: 10/21/2026
1 2 3